DNA X, Inc. (SONM) vs SOS Limited Unsponsored ADR (SOS)

DNA X, Inc. and SOS Limited Unsponsored ADR are both Capital Markets companies. SOS Limited Unsponsored ADR is the larger, with a market value of $7.4M against $3.4M — 2.1× the size. SOS Limited Unsponsored ADR grew revenue faster over the last twelve months: 93.1% against 4.17%. DNA X, Inc. has the higher net margin (0.00% vs −57.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, SOS Limited Unsponsored ADR leads on 6 and DNA X, Inc. on 5.

Valuation

Metric SONM SOS Capital Markets median
P/E n/m n/m 14.35
P/S 0.05 n/m 2.07
P/B n/m n/m 1.36
Price to free cash flow n/m n/m 9.28
EV/EBITDA 0.35 — —
EV/Sales 0.06 — —
Earnings yield (390.59%) (42.11%) (8.28%)
Free cash flow yield (355.70%) (21,349,788.26%) (1.12%)

Profitability

Metric SONM SOS Capital Markets median
Gross margin 0.00% (1.57%) 68.15%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (57.93%) (0.34%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 666.17% 0.00% 0.00%
Return on assets (42.11%) 0.00% 0.00%
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SONM SOS Capital Markets median
Revenue growth (TTM) 4.17% 93.12% 19.72%
EPS growth (last fiscal year) 77.74% (34.08%) 16.79%
Revenue growth, 5-year CAGR (12.89%) 25.13% 17.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SONM SOS Capital Markets median
Debt to equity 0.00 0.00 0.07
Current ratio 0.57 9.72 1.51
Net debt to EBITDA 1.18 0.06 (0.03)

Dividend

Metric SONM SOS Capital Markets median
Dividend yield — — 1.58%
Payout ratio — — 0.19

Size

Metric SONM SOS Capital Markets median
Market cap 3.42m 7.35m 527.01m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack